Matthew Dallas

Matthew Dallas joined CoLucid Pharmaceuticals, Inc., as Chief Financial Officer in February of 2015. Prior to joining CoLucid, he was the VP of Finance and Treasurer at AVEO Oncology, with responsibility for the company’s finance, IT and facilities functions. Mr. Dallas previously worked at Genzyme Corporation, NEN Life Sciences and Kimberly-Clark Corporation, where he held various positions in finance and accounting. He has 18 years of finance experience, including 16 in the biotech/life science industry, and holds a B.S. in finance from the University of Tennessee in Knoxville.